Rhabdoid Tumor Predisposition Syndrome: Symptoms and Risks

Rhabdoid tumor predisposition syndrome is a rare genetic condition that increases the risk of developing aggressive tumors, known as rhabdoid tumors. This syndrome can have a significant impact on health by predisposing affected individuals to the development of these tumors at a young age. The primary effect of rhabdoid tumor predisposition syndrome on well-being is the increased risk of developing cancerous growths that can affect various parts of the body.

What are the Types of Rhabdoid Tumor Predisposition Syndrome?

Rhabdoid tumor predisposition syndrome refers to a group of genetic conditions that increase the risk of developing rhabdoid tumors—rare and aggressive cancers, mainly affecting young children. These syndromes are caused by specific genetic mutations that make tumor formation more likely. If there is a family history of rhabdoid tumors or related conditions, genetic testing and counseling can help assess the risk and guide preventive steps. Early detection is crucial, as it allows for timely intervention and better management, improving the chances of positive outcomes for affected individuals.

SMARCB1 deficient Rhabdoid Tumor Predisposition Syndrome: This type is caused by mutations in the SMARCB1 gene, leading to an increased risk of developing rhabdoid tumors in various organs.
INI1 deficient Rhabdoid Tumor Predisposition Syndrome: INI1 deficient syndrome is characterized by mutations in the SMARCB1 gene, resulting in a predisposition to rhabdoid tumors, particularly in the brain and kidneys.
BRG1 deficient Rhabdoid Tumor Predisposition Syndrome: BRG1 deficiency syndrome is linked to mutations in the SMARCA4 gene, increasing the likelihood of developing rhabdoid tumors in different parts of the body, including the central nervous system.
SMARCA4 deficient Rhabdoid Tumor Predisposition Syndrome: This type is associated with mutations in the SMARCA4 gene, leading to an elevated risk of rhabdoid tumor development, especially in the brain, kidneys, and soft tissues.
ARID1A deficient Rhabdoid Tumor Predisposition Syndrome: ARID1A deficiency syndrome involves mutations in the ARID1A gene, resulting in an increased susceptibility to rhabdoid tumors, commonly found in the central nervous system and various organs.

What are the Symptoms of Rhabdoid Tumor Predisposition Syndrome

Rhabdoid Tumor Predisposition Syndrome is a genetic condition that increases the risk of developing certain tumors, including those in the kidneys. Individuals with this syndrome may experience developmental delays, intellectual disabilities, and behavioral issues. Regular medical check-ups are essential to monitor for tumor development and manage any associated health concerns early.

Developmental delays
Intellectual disability
Behavioral issues
Seizures
Vision problems
Hearing loss
Kidney abnormalities
Skin abnormalities
Susceptibility to certain types of tumors

What are the Causes of Rhabdoid Tumor Predisposition Syndrome?

Rhabdoid tumor predisposition syndrome is caused by genetic mutations that affect the SMARCB1 gene. This gene is responsible for preventing cells from growing and dividing too rapidly. When mutations occur in the SMARCB1 gene, it can lead to the development of rhabdoid tumors. Children with this syndrome have an increased risk of developing these tumors in various parts of the body.

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

SMARCB1 Gene Mutation
Germline Mutations in SMARCB1
Inherited Predisposition to Rhabdoid Tumor
Family History of Rhabdoid Tumors

How is RTPS Inherited?

Rhabdoid Tumor Predisposition Syndrome (RTPS) is usually caused by a change in the INI1 gene. It can be inherited in two ways:

Inherited from a Parent:

If a parent carries an altered INI1 gene, there’s a 50% chance of passing it to their child. Children who inherit this alteration are at risk of developing RTPS, including rhabdoid tumors and/or multiple schwannomas.

New Mutation:

In many cases, RTPS occurs due to a new mutation in the sperm, egg, or a developing fetus. This means the affected individual is the first in their family to have the condition.

Some people may also develop RTPS due to a DNA deletion that affects INI1 and other genes. This can lead to additional issues like birth defects, developmental delays, or intellectual disabilities, depending on the size of the deletion. In cases where the deletion includes INI1, rhabdoid tumors are the most common concern, though not necessarily schwannomas.

How is Rhabdoid Tumor Predisposition Syndrome Diagnosed?

Rhabdoid tumor predisposition syndrome is diagnosed by evaluating symptoms, family history, and genetic testing. Doctors look for specific signs of the condition and assess whether there is a family history of related tumors. Genetic tests help confirm the presence of mutations linked to the syndrome. In some cases, imaging tests like MRIs or CT scans, along with biopsies, may be needed to detect tumors. Consulting a specialist in genetic disorders is important for an accurate diagnosis and to determine the best approach for monitoring and treatment.

Genetic Testing: Identifies mutations in specific genes linked to the syndrome.
Imaging Studies: MRI, CT scans, or ultrasounds help detect tumors in the kidneys and other organs.
Biopsy: Biopsy is a tissue sample from a suspected tumor is examined to confirm the diagnosis.

Treatment for Rhabdoid Tumor Predisposition Syndrome

Rhabdoid tumor predisposition syndrome is a rare genetic condition that increases the risk of developing tumors, especially in young children. Managing this condition requires a team of specialists and a personalized treatment plan.

Surgery: The primary treatment for rhabdoid tumor predisposition syndrome involves surgical removal of the tumor to prevent its spread and reduce the risk of recurrence.
Chemotherapy: Chemotherapy drugs may be used to target and kill cancer cells that remain after surgery or to shrink the tumor before surgery.
Radiation Therapy: Radiation therapy uses high energy beams to destroy cancer cells and may be recommended in cases where the tumor cannot be completely removed surgically.
Stem Cell Transplant: In some cases, a stem cell transplant may be considered to help restore healthy blood cells after high dose chemotherapy or radiation therapy.
Clinical Trials: Participation in clinical trials exploring new treatment options and targeted therapies may be beneficial for individuals with rhabdoid tumor predisposition syndrome that does not respond well to conventional treatments.

What are the Risk Factors of Rhabdoid Tumor?

Rhabdoid tumor predisposition syndrome is a rare genetic condition that increases the risk of developing aggressive tumors. The main risk factors for this syndrome are specific genetic mutations that affect how cells grow and divide. These mutations can be inherited from a parent or occur spontaneously. Early detection and genetic testing are crucial to manage the risk associated with this syndrome.

Your health is everything - prioritize your well-being today.

Schedule Your Appointment

Genetic predisposition: Inherited mutations increase susceptibility.
Family history of rhabdoid tumor: A close relative with a rhabdoid tumor raises the risk.
Germline mutation in the SMARCB1 gene: A key genetic abnormality linked to the syndrome.
Young age at diagnosis: Most cases occur in infancy or early childhood.
Diagnosis of malignant rhabdoid tumor in the past: A history of these tumors suggests an increased likelihood of recurrence or additional tumor development.

What Are the Prenatal Genetic Testing Options for Individuals with RTPS Concerned About Passing It On?

For individuals with RTPS concerned about passing it on to their children, there are two main prenatal genetic testing options:

Prenatal Diagnosis:

This involves testing the embryo’s DNA via chorionic villus sampling (CVS) or amniocentesis to check for mutations in the INI1 gene. Based on the results and genetic counseling, parents can decide whether to continue or end the pregnancy.

Preimplantation Genetic Diagnosis (PGD):

For those using in vitro fertilization (IVF), embryos are tested for the INI1 gene mutation before being implanted in the uterus. Only embryos without the mutation are chosen for implantation.

Find Our Specialists

Book Doctor Appointment

Name*

Mobile Number*

I agree to the Medicover Privacy Policy

International Patient Services

Still have questions? Speak with our experts now!

040-68334455

Frequently Asked Questions

Symptoms of rhabdoid tumors in babies may include swelling or a lump in the abdomen, unexplained pain, vomiting, or difficulty breathing. These tumors often present rapidly, causing significant distress. Early diagnosis is crucial for effective management.

The survival rate for rhabdoid tumors can vary based on factors like tumor location, size, and stage at diagnosis. Treatment advances have improved outcomes, but the prognosis can remain challenging due to the aggressive nature of the tumor.

Rhabdoid features typically involve large, irregular-shaped tumor cells with a distinct appearance under a microscope. These tumors are highly aggressive and often infiltrate surrounding tissues, making them difficult to treat.

Rhabdoid tumors commonly involve mutations in the SMARCB1 gene, also known as the INI1 gene. This gene plays a role in regulating tumor growth, and its loss leads to the formation of rhabdoid tumors.

Rhabdoid tumor predisposition syndrome type 2 is a genetic condition that increases the risk of developing rhabdoid tumors. It involves mutations in the SMARCB1 gene, leading to an increased likelihood of these aggressive tumors in children.